Selection of PPI in a comorbid patient with NSAIDgastroesophagopathy: case study

Over the past decades, there have been significant changes in the structure of adult morbidity. Clinicians are increasingly faced with the problems of combined pathology and development of comorbidity, as well as to solve the issues of rational tactics of management of such patients. Polypragmasia d...

Full description

Bibliographic Details
Main Author: I. G. Pakhomova
Format: Article
Language:Russian
Published: Remedium Group LLC 2019-05-01
Series:Медицинский совет
Subjects:
Online Access:https://www.med-sovet.pro/jour/article/view/3003
_version_ 1797842126547976192
author I. G. Pakhomova
author_facet I. G. Pakhomova
author_sort I. G. Pakhomova
collection DOAJ
description Over the past decades, there have been significant changes in the structure of adult morbidity. Clinicians are increasingly faced with the problems of combined pathology and development of comorbidity, as well as to solve the issues of rational tactics of management of such patients. Polypragmasia due to comorbidity leads to a sharp increase in the probability of developing systemic and undesirable effects of drugs, while prolonged use of several drugs can lead to the development of complications that develop into independent nosological forms, which is especially important in older age groups. The most common forms of comorbidity in the elderly are in one or another combination of the following diseases: hypertension, coronary heart disease, diabetes, diseases of the musculoskeletal system. It is known that the leading place in the relief of pain in the latter is occupied by non-steroidal antiinflammatory drugs (NSAIDs), the use of which can be prolonged and induce the development of serious gastrotoxic reactions. Well studied and described NSAIDs-induced gastropathy, which, in most cases, is asymptomatic even in the presence of erosive and ulcerative changes. However, NSAIDs may be associated with the emergence of various dyspeptic complaints and lesions of the esophagus, which can be viewed in the framework of NSAID-associated esophageal, especially relevant in older patients. The article deals with the problem of comorbidity, polypragmasia, therapeutic tactics in the management of comorbid patients with NSAIDsesophagogastropathy and the possibility of prescribing for the prevention and treatment of not only effective, but also safe means of correction of these clinical and endoscopic manifestations.
first_indexed 2024-04-09T16:42:41Z
format Article
id doaj.art-c50801d44f494e73b744c55ede79233c
institution Directory Open Access Journal
issn 2079-701X
2658-5790
language Russian
last_indexed 2024-04-09T16:42:41Z
publishDate 2019-05-01
publisher Remedium Group LLC
record_format Article
series Медицинский совет
spelling doaj.art-c50801d44f494e73b744c55ede79233c2023-04-23T06:56:37ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902019-05-0103485410.21518/2079-701X-2019-3-48-542922Selection of PPI in a comorbid patient with NSAIDgastroesophagopathy: case studyI. G. Pakhomova0Federal State Budgetary Educational Institution of Higher Education «Mechnikov North-Western State Medical University» of the Ministry of Health of the Russian FederationOver the past decades, there have been significant changes in the structure of adult morbidity. Clinicians are increasingly faced with the problems of combined pathology and development of comorbidity, as well as to solve the issues of rational tactics of management of such patients. Polypragmasia due to comorbidity leads to a sharp increase in the probability of developing systemic and undesirable effects of drugs, while prolonged use of several drugs can lead to the development of complications that develop into independent nosological forms, which is especially important in older age groups. The most common forms of comorbidity in the elderly are in one or another combination of the following diseases: hypertension, coronary heart disease, diabetes, diseases of the musculoskeletal system. It is known that the leading place in the relief of pain in the latter is occupied by non-steroidal antiinflammatory drugs (NSAIDs), the use of which can be prolonged and induce the development of serious gastrotoxic reactions. Well studied and described NSAIDs-induced gastropathy, which, in most cases, is asymptomatic even in the presence of erosive and ulcerative changes. However, NSAIDs may be associated with the emergence of various dyspeptic complaints and lesions of the esophagus, which can be viewed in the framework of NSAID-associated esophageal, especially relevant in older patients. The article deals with the problem of comorbidity, polypragmasia, therapeutic tactics in the management of comorbid patients with NSAIDsesophagogastropathy and the possibility of prescribing for the prevention and treatment of not only effective, but also safe means of correction of these clinical and endoscopic manifestations.https://www.med-sovet.pro/jour/article/view/3003comorbiditypolypharmacynsaidgastro esophagoplastynsaidsppispantoprazole
spellingShingle I. G. Pakhomova
Selection of PPI in a comorbid patient with NSAIDgastroesophagopathy: case study
Медицинский совет
comorbidity
polypharmacy
nsaid
gastro esophagoplasty
nsaids
ppis
pantoprazole
title Selection of PPI in a comorbid patient with NSAIDgastroesophagopathy: case study
title_full Selection of PPI in a comorbid patient with NSAIDgastroesophagopathy: case study
title_fullStr Selection of PPI in a comorbid patient with NSAIDgastroesophagopathy: case study
title_full_unstemmed Selection of PPI in a comorbid patient with NSAIDgastroesophagopathy: case study
title_short Selection of PPI in a comorbid patient with NSAIDgastroesophagopathy: case study
title_sort selection of ppi in a comorbid patient with nsaidgastroesophagopathy case study
topic comorbidity
polypharmacy
nsaid
gastro esophagoplasty
nsaids
ppis
pantoprazole
url https://www.med-sovet.pro/jour/article/view/3003
work_keys_str_mv AT igpakhomova selectionofppiinacomorbidpatientwithnsaidgastroesophagopathycasestudy